With the help of its own Innovation Task Force (ITF), the European Medicines Agency (EMA) aims to help developers to replace, reduce and refine animal testing during the development, manufacture and testing of human and veterinary medicines.

The annual EPAA event on October 27th, will give participants insight into EPAA’s achievements in 2021, announce the EPAA Refinement Prize winner, and discuss our role in the EU chemical strategy for sustainability.

To raise awareness about the advantages of animal-free produced antibodies and promote their development and application, the European Coalition to End Animal Experiments (ECEAE) is announcing for the first time a Prize for animal-free antibodies. The aim of this prize is to highlight the versatility and superiority of animal-free antibodies and encourage their acceptance and use for research and therapeutic purposes.

To find out more precisely how the SARS-CoV-2 virus manages to evade immune defenses and replicate in the cells of patients, an international research team involving the Technical University of Munich broke new ground with artificial intelligence. They succeeded in compiling the most comprehensive and detailed overview to date of all the 3D structures of the virus proteins available worldwide. In a database, this information is publicly available for research.